Physician profile
Peter R Scott
NPI 1326126269
$5,928.77
in general payments reported to CMS, 2019-2025
40 companies · $579 in 2025
The $579 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,217 · 2020: $279 · 2021: $296 · 2022: $1,184 · 2023: $1,179 · 2024: $1,196 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,952 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,952.38 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,191.06 | 2019-2025 | Lifevest |
| Pfizer INC. | $723.50 | 2019-2025 | |
| Edwards Lifesciences Corporation | $582.52 | 2019-2025 | Sapien 3 Ultra Resilia |
| Amgen INC. | $345.74 | 2019-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $293.38 | 2020-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $275.46 | 2022-2025 | Watchman Flx, Watchman, Watchman Access System |
| Merck Sharp & Dohme LLC | $271.64 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $224.50 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $195.90 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $186.59 | 2019-2024 | |
| Lantheus Medical Imaging, INC. | $150.57 | 2019-2021 | |
| Abbott Laboratories | $146.64 | 2022 | |
| Abiomed | $129.64 | 2022-2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.56 | 2019-2023 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $112.05 | 2024 | Arcalyst |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.